Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Stroke | Phase 2 | ClinicalTrials |
| Purpura; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic | Phase 2 | ClinicalTrials |
| Fatigue | Phase 2/Phase 3 | ClinicalTrials |
| Intracranial Hemorrhages; Stroke | Early Phase 1 | ClinicalTrials |
| Fatigue | Phase 2/Phase 3 | ClinicalTrials |
| Neoplasm Metastasis; Neoplasms; Recurrence | Phase 1/Phase 2 | ClinicalTrials |
| Fatigue | Phase 2 | ClinicalTrials |
CONTENTS